ABSTRACT: Various alkaloids found in enclophvteinfected tall fescue have been shown to elicit different effects in the grazing animal. As part of an ongoing characterization of vascular response generated b y different alkaloids, the objective of this study was to examine the vasoconstrictive potentials of ergonovine (a simple lysergic acid derivative) and c(-ergocryptine, ergocristine, and ergocornine (all ergopeptine alkaloids) using bovine lateral saphenous veins (cranial branch) biopsied from fescue-naïve cattle. Segments (2 to 3 cm) of vein were surgically biopsieci from healthy crossbred yearling cattle (n = 18: 274 ± 8 kg of MV). Veins were trimmed of excess fat and connective tissue, sliced into 2 to 3 mm sections, and suspended in a rnyographi chamber containing 5 ml, of oxygcnatcdl Krebs-Henseleit buffer (95% 0 2/5% C09; pH = 7.4; 37°C). Tissue was allowed to equilibrate at 1 g of tension for 90 miii before initiation of treatment additions. Increasing doses of each alkaloid (1 x 10° to 1 x 10 1 Al) were administered every 15 min after buffer replacement. Data were norrnalized as a percentage of contractile response induced by a reference close of norepinephrine (1 x 10-' Al). Exposure of vein segments to increasing concentrations of ergocryptine. ergocristine, and ergonoviiie (lid not result in a contractile response until 1 x 10 41. and ergocornine was even less potent (P < 0.05). Ergonovine had a greater iiiaximal contractile intensity than ergocristine and ergocryptine (P < 0.05), with the 1 x 10 Al responses of ergonovine, ergocnistine, ergocryptine, and ergocornine reaching maximums of 68.5 + 4.1. 45.5 ± 4.5. 42.9 + 4.1%. and 57.2 ± 9.9% of the norepinephrine maximum, respectively. The contractile response to increasing concentrations of ergonovine vs. ergocryptine, ergocristiue, and ergocornine were opposite from previous evaluations of ergoline (e.g.. lysergic acid) and ergopept iie (e.g., ergovaline) alkaloids using this bioassay. where the ergopeptine generated the greater contractile intensit y. These data indicate that ergopeptires structurally different only at a single position of the peptide moiety do not exhibit differing contractile responses when considering contractile intensit y. This diffirence may alter the potency when considering ergocornine was less potent than ergocryptine or ergocristine. These alkaloids may need to be considered when evaluating causative agents vasoconstriction associated with tall fescue-induced toxicosis.
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INTRODUCTION
Mention of I rod' iiann', proprietaryproduct, or specified equip ment does not (:oiistit ute ii guiarauitt'e or warranty b y the USDA and Peripheral vasoconstriction in grazing animals is a response attributed to alkaloids (Strickland et at, 2009) found in endophyte-iiifected tall fescue (Lolium arnndznaceum) . The endlophvte (Neof.yphodium, cocnophial'am) produces numerous ergot alkaloids (Yates et al., 1985) that have an ergoline ring moiet y as a common structural feature. Derivatives of the ergolinc ring system can be structurall y categorized as ergolinie alkaloids (e.g., lysergic acid: Figure 1A ), simple lysergic acid derivatives (e.g., ergonovine: Figure 113 ), and ergopeptinc alkaloids (e.g.. ergovaline: Figure 2 ; Garner et al,. 1993) . Ergopeptine alkaloids have a tric yclic peptide moiety attached via a carbonvl at the 8 position in the D ring that differs at 2 locations (designated as R1 and R2: Figure 2A ) and results in different ergopeptine alkaloids that can be grouped by structural similarities at the R 1 and R 2 positions ( Figure 2B ).
Lysergic acid and ergovaline have both been proposed as toxic components of endopliyte-infected tall fescue (Lyons et al., 1986 : Hill et al.. 2001 and have recently been shown to elicit different contractile responses (Klotz et al.. 2008) . Specifically, ergovahine had a greater potency and contractile intensity than lysergic acid. Furthermore, ergovaline and ergotannnc (both ergopeptine alkaloids) structurally differ only at the H2 position, and it has becii demonstrated that they generate the same contractile response (Klotz et al., 2007) . As a result, it was hypothesized that u-ergoeryptine, irgocristinc, and ergocorniie, winch also differ only at the R2 positions, would generate similar contractile respouses, but would (lifter from that of the simple lvsergic acid derivative, ergonovirie (a 2-propanolanude derivative of lysergic acid). Therefore, the objective of this experiment is to compare the vasoconstrictive potentials of 3 ergopeptine alkaloids that differ only at I lie R position and ergonovine using lateral saplienous veins hiopsied from fescue-naïve cattle.
MATERIALS AND METHODS
I\ Fethods used for the biopsies were approved by the University of Kentucky Institutional Animal Care and Use Committee.
Animals and Tissues
Lateral saphenous vein (cranial branch) tissue used in this stud y was collecte via surgical biopsy from fescue-naIve Angus x Braiigus crossbred heifers (n = 18; 274 ± 8 kg of BW: obtained from the USDA-ARS. Dale Bumpers Small Farms Research Center, Booneville, AR) using methods reported by Klotz et a.l. (2008) . Heifers were maintained in a drylot oil corn silage diet before biopsy. The biopsy consisted of placing the animal in a left lateral recumbency using a lilt table (Spring-0-Matic Inc., Marion, KS). and the biops y site was clipped free of hair, cleaned (poviclone-iodine soap solution), disinfected (70% ethyl alcohol), and locally anesthetized (lidocaine. 2% injectible: The Butler Co.. Dublin. OH). A 10-cm incision was made in the tarsal region, slightly above and parallel to the target vein. After identification of the cranial branch of the lateral saphenous vein, ligatures were placed after the division of the lateral saphenous vein into cranial and caudal branches and before the cranial branch merged with a branch of the cranial tibial vein. The isolated yelions tissue was excised and placed in a mnodified-Krebs llenseleit oxygenated buffer solution (95% 02/5% CO2: pH = 7.4: mM composition = D-glucOse, 11.1: MgS01. 1.2: KHP0. 1 . 1.2; NC!, 4.7; NaCl. 118.1; CaC12, 3.4: and NaHCO:m. 24.9; Sigma Chemical Co., St. Louis, MO) for transport and kept on ice until processed. Tinmediately after biopsy, heifers received penicillin (Procaine C. 6,600 U/kg of BW: Norhrook Inc.. Kansas City, MO) and flunixin inegh.mmiune (Flunixiject. 1.1 tug/kg of MV: IVX Animal Health Inc.. St.. Joseph. MO) and were returned to the drvlot for observation. The administration of flunixin meglumine continued for 2 (1 post biopsy.
Tissue processing consisted of removal of excess fat and connective tissue and the cleaned segment was sliced into 2-to 3-mm cross-sections. Cross-sections were examined under a dissecting microscope (Stemi 2000-C. Carl Zeiss Inc.. Oberkochen. Germany) at Example of typical responses of isolated bovine lateral sa plienou Vein UF iss-sect 11)115 to increasing concentrations if ergoiinVili(. o-ergocryptine, ergocristine and ergocornine. Venous tissue was biopsied front fescue-naive heifers, and the complete data recording froin the mnvograph includes initial addition of norepinephrine (NE). the addition of the alkaloid standards, and the concluding addition of NE. The spikes that precede compound additions are artifacts generated from buffer replacement and were not included in the data collection and analysis.
12.5x magnification to measure dimensions for assurance of consistent segment size and to verify physical integrity of tissue. Cross-sections were suspended horizontally in a 5-niL tissue bath (DMT610M Multichamber myograph, Danish Myo Technologies, Atlanta, GA) containing continuously oxygenated modifiedKrebs Henseleit buffer (95% 0 2/5% CO,; pH 7.4; 37C), with 3 >< 10-5 Al desipramine and 1 x 10_6 M propranolol (Sigma Chemical Co.) to inactivate catecholarnine-neuronal uptake and -adrenergic receptors, respectively. After equilibration to 1 g of tension (1.5 11), tissues were exposed to the -adrenergic agonist norepinephrine (1 x 10 -4 Al; Sigma Chemical Co.) to verify tissue viability and as a reference for normalization of the corresponding contractile responses (Klotz et al., 2006) .
Evaluation of Ergonovine, Ergocryptine, Ergocristine, and Ergocornine
Cross-sections of lateral saplienous veins were run in duplicate from each animal for each alkaloid experiment. The uneven distribution of veins across treatments (n 6 for ergonovine and ergocryptine, n 5 for ergocristine, and n = 4 for ergocornine) was a result of some experiments being conducted on the same animals and some biopsies yielding unviable tissue (contractile response to 1 x 10' Al norepinephrine less than 10 g). After recovery from the 1 x 10-4 M norepinephrine addition (45 to 60 mm) and the reestablishment of the 1 g baseline tension, alkaloid additions occurred in 15-min intervals. Each 15-min interval consisted of a 9-inin incubation period, followed by a washout period Klotz et al. during 
After the final addition of an alkaloid, the experiment was concluded with a final addition of I x 10 Al norepinephrine to verify that the vein cross-sections were still viable at the conclusion of the experiuleut.
Stock standards of crgollovine rnaleate (100% purity, E6500, Sigma Chemical Co.), (wergocr yptine (991X, purity, E5625, Sigma Chemical Co.), and ergocristine (^97% purity, E140. Signia Chemical Co.) were prepared in 100% methanol (EMD Chemicals. Gibbstown. NJ). Ergocornine (>95% purit y . E131. Sigma Chemical Co.) was not soluble in methanol; thus, standards were prepared in 100% eth y l acetate (Fisher Scientific. FailLawn, NJ). To achieve a 1 x 10 Al concentration in the incubation buffer, a 2 x 10 2 Al stock Concentration was prepared for each alkaloid. Serial dilutions of this stock made up the remaining standards and 25-tiL aliquots of the dilutions were added to tIe incubation huff.r to attain desired treatment conceiitritioiis (1 x 10-10 to 1 x 10 M. Using this protocol, organic solvent concentrations in the incubation buffer were kept below 0.5%.
Data Collection and Analysis
Isometric contractions were recorded as grams of tension in response to exposure to norepinephri lle. and the subsequent additions of ergonovine, n-ergocryptine.
ergocristmne. or ergocorniuc. Data were digitized and recorded using a Powerlab/851) and Chart software (Version 5.5; A Diristruinents, Colorado Springs. CO). The contractile responses were recorded as the greatest grams of tension detected within the 9-min incubation period. All maximal values measured were corrected by the baseline measured during the interval just preceding the addition of the norepinephriue (1 x I0 It/i) reference treatment. thus generating cumulative contractile responses. To compensate for variation of tissue responsiveness due to differences in tissue size or individual animal variation, values were normalized as a percentage of the maximal contraction produced by norepiiieplim'iiie Contractile response data are presented as percentage means + SE of the maximum effect (E 111. 1 ) of a contraction induced b y norepinephm'ine and plot ted to illustrate the response of the bovine lateral saphenous vein. Potency of all was determined as the molar concentration of the alkaloid producing 50% of the maximum response or effective concentration (EC 50 ) and was calculated from the contractile-response data using the Dose Response Module for Chart (Version 1.0. 2007. ADinstrunients)
The understanding of the relative vasocoilstrjct strength of the different alkaloids isolated froni en-(lOphiyte-imifectecl tall fescue in all model is incomplete. Thins far foi' the bovine model. lvsel'gic acid, ergovaline, ergotannue, and N-a.cetylloline have been evaluated using the lateral saphienous vein bioassay (Klotz et al., 2006 (Klotz et al., , 2007 . Additionally, bovine contractile responses have been reported for ergosinc, ergotaniimie. agroclavine (Solomnons et al.. 1989 ), all(] ergonovimle (Oliver et al., 1992 ) using the dorsal pedal vein: lysergamimide using the lateral saphenous vein (Oliver et al., 199: 3); and ergovalme using uterine and umbilical arteries (Dyer. 1993). Fora-erg ergocnistine arid ergocornimie, there are few contractilit v data, and none using the bovine model . The current study reports the evaluation of the vasoconstricf,iye responses of the comliniercially available ergonoviime, ('e-ergocrvptjne. ergocristine, and ergocornine alkaloids using a bovine lateral saphenous vein bioassay.
Exposure of lateral saphienouis veins from tall fescuenaïve heifers to increasing concentrations of ergonovimie, -ergocryptine, ergocristine and ergocormnne resulted in dose-dependent contractile responses that were evident in the traces presented in Figure 3 . All 4 alkaloids had a cumulative concentration response as there was negligible recovery during the rinse buffer replacements before subsequent alkaloid additions. This is typical of previous reports for ergopeptimie alkaloids (Klotz et al., 2007 (Klotz et al., , 2008 7 but ergonoville was expected to behave more like lysergic acid, which is easil y rinsed fi'onu the system allowing the vein segments to return to baseline tension (Klotz et a,!., 2006) .
The normalized data were plotted as contractile re sponses as a percentage of the corresponding norepinephrimie maximum against (lie increasing concentrations of each alkaloid, and best-of-fit pol ynomial curves were calculated for all alkaloids evaluated (Figure 4 ).
Responses to all 4 alkaloids were quadratic (P < 0.01), with positive x 2 coefficients, positive slopes, and no detectable contractile response below 1 x 10' Al. Al-
Statistical Analysis
Concentration responses of ergoliovine. C-ergocryptine, ergocristine, and ergocorrmine were compared to (leternhine if the alkaloids elicited different responses Data for each alkaloid were anal y zed as a completely randomized (lesigli using the mixed model procedure (SAS Inst.. Inc., Cam' y . NC). Animal was the experilnem tal unit and time model included alkaloid, concentration and alkaloid x concentration effects. ANOVA was conducted, and pairwise comparisons , of least squares means (+SEPvI) were performed if the probability of a greater F statistic was significant for the tested effect Additionally . the probabilities of linear, quadratic, and cubic effects of alkaloid relative to concentration were determined and evaluated as a test for het erogeneitv of slopes (Littell, et al., 2006) . Terms and associated interactions that were not significant were removed from model. Effects and comliparisons were considered different at P < 0.05. Means within a (01110111 not sharing like superscripts are different (P < 0.05).
RESULTS AND DISCUSSION
I ECTIO = the potency of an agonist expressed as the molar coneeti!ralion producing 50 of the maximum E ,, = the maximal contractile response expressed as ii percentage of the 1 x 10 Al norepinephrine reference addition.
though all 4 alkaloids had significant q1iclrtttic effects. the slope of ergollovine was greater (P < 0.1)1) than ergocrvptine. ergoc.orlune, and ergocrist.ine, which all had similar slopes. The effects of alkaloid, concentration, and alkaloid by concentration were all significant.. The E,fl ,\ (i.e., contractile intensities at the I x 10-' M response) are listed in Table I for each alkaloid evaluated. Ergonovine had the greatest E.. (68.5 + 4.1%) when compared with ergocryptme and e.rgocrist.ine (P < 0.05), but was not different than the Efl ,5 for ergocornme (P = 0.29). This was opposite to previous observations of ergohne (e.g.. lysergic acid) and ergopeptide (e.g.. ergovaline) alkaloids using this bioassay, where the ergopeptinc alkaloid generated the greater
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Concentration, 1 xlO M Figure 4 . il,',in contractile responses of tall fesCue 1]aiv( bovine aphieuiouis \eiltS to iuIcreulsiuig ('oIlel'lltl,ltil,lls of ergonoviute (•: ii = 6). o-ergoerypt inc (: n -6), ergoerist joe (0: n = 5), and ergocornine (: n = 1). The best-of-fit pol ynomial lines demonstrate the effect of alkaloid concentration on contractile response for eia'li alkaloid. Line equations are y = 3.2x ± 56.6x + 217.8. r 2 = 0.98 for erg000vinc:
2. 1x 37.5x + 159.9, 1-' = 0.99 for o-ergoervpt iuic: y = 2.1 x 2 ± 37.9x 164.1. r2 = 0.99 for ergocrist me: and y = 2.4x2 + 43.lx + 186.6. r2 -0.99 for ergocornine. Effects of alkaloid and concentration were hotli significant (P < 0.01). and the alkaloid x concentration was also significant (P = 0.03).
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contractile intensity (Klotz et al.. 2008 ). The EC 50 or potency of ergocornine (Table 1) was approximately 10-fold greater or less potent that ergonovine, ergocristine, or ergocryptine (P < 0.05).
The hypothesis that ergopeptines that differ at the R.9 position (e.g., ergocryptine, ergocristine, and ergocornme consisting of the AA leucine. phenylalanine, or valine, respectively), but riot the R 1 , will generate similar contractile responses was strengthened with the cornparisori of a-ergocryptine, ergocristine, and ergocorrune not resulting in different Enia x values (Table 1) or slopes (Figure 4 ) in this experiment. This is also in agreement with the comparison of ergovaline and ergotamine by Klotz et al. (2007) , which resulted in similar contractile responses. Further, the structural differences between ergonovine and the 3 ergopeptines resulted in different contractile response slopes and for ergocryptinc and ergocristine. This lends credence to the possibility that the differences in the ergopeptines at the R 1 group have a greater irnpact oil binding and vasoconstriction than differences at the R2 position. This differs from a report by Solornons et al. (1989) where ccgotamirie and ergosine ( Figure 213 ; differ only at the R.9 position) were evaluated using the bovine dorsal pedal vein model. Ill model, ergot amine was found to be more potent and generated greater mean maximal contraction than ergosine.
The Eriiaa and ECn) values for ergovaline and lysergic acid were calculated from data obtained from biopsied fescue-naïve bovine lateral saphenous veins originally reported by Klotz et al. (2008) . The inclusion of these ancillary data allows the comparison of structural differences at the R 1 position to demonstrate differences in contractile response. When considering ergovaline and ergocornine ( Figure 2B ), which differ at the R 1 and not the R2 . the difference in E 111;Ix is doubled and the EC50 is an order of magnitude less for ergovaline (E1 = 104.1 ± 6.0% of norepinephrine maximum; EC 50 = 4 x 10 -6 1.5 x 10 Al) compared with ergocornine (Table 1) . Conversely, when comparing the E rix and EC50 for lysergic acid and ergonovine, it is evident that the presence of the 2-propanolamide on the ergoline ring ( Figure 1B ) results in air that is triple and an EC50 that is ail of magnitude less for ergonovinc (Table 1) over that of lysergic acid ( E uax = 22.6 + 4.1% of norepinephrine maximum; EC 50 = 5.5 x 10 5 ± 2.3 x i0 Al).
The subtle structural differences at the ergopeptine alkaloid R1 arid R.9 positions ( Figure 2B ) and the influence these differences appear to have oil potency arid efficacy of stimulating a vascular response is likely the result of alkaloid-receptor interactions. Ergot alkaloids have been shown to act as ligancls at serotinergic, dopaminergic, and adrenergic receptor sites (Berde and Stiirmer, 1978: Portz and Eich, 1999) and these receptors are G protein-coupled intrinsic membrane proteins with 7 transmemnbrane helices (Goddard and Abrol, 2007) . Chouclhary et al. (1995) demonstrated that the presence or absence of a highly conserved aromatic residue (phenylalanjne at the 340-position) in the serotonin receptor alters hi gh affinity binding of simple ergoline alkaloids (e.g., of tested ergoline -ergonovine), but had little effect oil binding of ergopeptine alkaloids (e.g.. of tested ergopeptines ergocryptine, ergocornine, and ergotanune). As knowledge about the 3-climenstional structure of these receptors and the hiimding sites of agonists and antagonists increases, findings are suggestirig thatthe structure of the substituent attached to the 8-postion of the ergoline ring (Figure 2A ) results in different modes of binding (Choudhary et al., 1995) . These different modes of binding calm influence whether an alkaloid acts as ail partial agonist, or air (Berde, 1980; Goddard and Abrol, 2007) . The difference in response between ergonovine and the more complex ergopeptine alkaloids in the current stud y may, he attributable to a smaller substituent, attached to the ergoline ring of ergonovine. This pseudo-13 1 group found oil suhstituerit of ergonovine (Figure 113 ) is a methyl group compared with the isopropyl group found oil R 1 of the 3 ergopeptirles ( Figure 213 ). Free rotation of this methyl group at the pseudo-R 1 position of ergonovine may better accommodate binding at a receptor site than the isopropyl groups of ergocryptine, ergocristine, and ergocormne. An understanding of the relationship an ergot alkaloid has with a receptor a'nd the resultant vascular response ma y he related to the chemical structure of that alkaloid; hence the type of binding structurally permissible may influence the subsequent signal transduction.
In conclusion, ergonovine is a potent alkaloid that generates ail contractile response. Ergocristine, m cn-ergocrypte. and ergocornine did not differ in contractile response, but (x-ergocryptine, ergocristirme had less E,,,,,, , ergonovine. Although ergoconmine appeared similar to -ergocryptine and ergocristine, it was less potent as evident by the greater ECn ) . It appeal's that structural differences in the R9 position of ergopeptines do not result in differences when evaluating contractile response. Conversely, the structural difference at the R 1 position resulting in the AA alanine for ergotamine, ergovaline, amid ergosine or valimie for cn-ergocryptine, ergocristine, and ergocomnine appears to have the potential to influence E i ax , arid possibly the potency of ergopeptine alkaloids. These observations on structural differences and how they affect ph ysical respouse will aid future research concerned with receptor binding of alkaloids arid the mmiec:hanismns b y winch alkaloids elicit the observed vasoconstrjctjve effects on grazing animals. 
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